MINI FUTURE LONG - NOVOZYMES B Share Price

Certificat

DE000ME39JA1

Market Closed - Börse Stuttgart 01:43:34 21/05/2024 pm IST
1.57 EUR -3.09% Intraday chart for MINI FUTURE LONG - NOVOZYMES B
Current month+63.54%
1 month+63.54%
Date Price Change
21/24/21 1.57 -3.09%
20/24/20 1.62 0.00%
17/24/17 1.62 +4.52%
16/24/16 1.55 +3.33%
15/24/15 1.5 +5.63%

Delayed Quote Börse Stuttgart

Last update May 21, 2024 at 01:43 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying NOVONESIS A/S
Issuer Morgan Stanley
WKN ME39JA
ISINDE000ME39JA1
Date issued 08/11/2023
Strike 313.4 kr
Maturity Unlimited
Parity 10 : 1
Emission price 0.55
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.65
Lowest since issue 0.5

Company Profile

Novonesis A/S (formerly Novozymes A/S) is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - industry of cleaning and household maintenance products (28.5%); - bioenergy (24.8%); - food industry and human health (22.1%); - technical and cereal industries (12.8%): microorganisms used in the field of wastewater treatment, technical enzymes intended for the textile, leather, pulp and paper industries; - agriculture and animal feed industry (11.8%): enzymes used to improve the productivity and digestion of certain foods. Net sales are geographically distributed as follows: Denmark (1.3%), Europe/Middle East/Africa (33.5%), North America (33.9%), Asia/Pacific (18.5%) and Latin America (12.8%).
Sector
-
More about the company

Ratings for Novonesis A/S

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Novonesis A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
428.7 DKK
Average target price
437.4 DKK
Spread / Average Target
+2.04%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW